Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model

被引:4
|
作者
Zhang, Xueying [1 ]
He, Zijun [1 ]
Zhang, Yucong [2 ]
Kong, Jian [3 ]
机构
[1] Jinan Univ, Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China
[2] Southern Univ Sci & Technol, Jinan Univ, Shenzhen Peoples Hosp,Clin Med Coll 2, Dept Radiat Oncol,Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China
[3] Southern Univ Sci & Technol, Jinan Univ, Shenzhen Peoples Hosp,Affiliated Hosp 1, Dept Intervent Radiol,Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China
关键词
hepatocellular carcinoma; drug-eluting beads transcatheter arterial chemoembolization; initial response; objective response; computed tomography; radiomics; nomogram; prediction; TRANSARTERIAL CHEMOEMBOLIZATION; LIVER-CANCER; TIME-POINT; DC BEAD; MRECIST; CLASSIFICATION; SURVIVAL; HETEROGENEITY; SYSTEM; EASL;
D O I
10.3389/fphar.2024.1315732
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: A prognostic model utilizing CT radiomics, radiological, and clinical features was developed and validated in this study to predict an objective response to initial transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma (HCC).Methods: Between January 2017 and December 2022, the baseline clinical characteristics and preoperative and postoperative follow-up imaging data of 108 HCC patients who underwent the first time treatment of DEB-TACE were analyzed retrospectively. The training group (n = 86) and the validation group (n = 22) were randomly assigned in an 8:2 ratio. By logistic regression in machine learning, radiomics, and clinical-radiological models were constructed separately. Finally, the integrated model construction involved the integration of both radiomics and clinical-radiological signatures. The study compared the integrated model with radiomics and clinical-radiological models using calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA).Results: The objective response rate observed in a group of 108 HCC patients who received initial DEB-TACE treatment was found to be 51.9%. Among the three models, the integrated model exhibited superior predictive accuracy in both the training and validation groups. The training group resulted in an area under the curve (AUC) of 0.860, along with sensitivity and specificity values of 0.650 and 0.913, respectively. Based on the findings from the validation group, the AUC was estimated to be 0.927. Additionally, it was found that values of sensitivity and specificity were 0.875 and 0.833, respectively. In the validation group, the AUC of the integrated model showed a significant improvement when contrasted to the clinical-radiological model (p = 0.042). Nevertheless, no significant distinction was observed in the AUC when comparing the integrated model with the radiomics model (p = 0.734). The DCA suggested that the integrated model demonstrates advantageous clinical utility.Conclusion: The integrated model, which combines the CT radiomics signature and the clinical-radiological signature, exhibited higher predictive efficacy than either the radiomics or clinical-radiological models alone. This suggests that during the prediction of the objective responsiveness of HCC patients to the first DEB-TACE treatment, the integrated model yields superior outcomes.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Enhancement Patterns of Hepatocellular Carcinoma After Transarterial Chemoembolization Using Drug-Eluting Beads on Arterial Phase CT Images: A Pilot Retrospective Study
    Chung, Woo-Suk
    Lee, Kwang-Hun
    Park, Mi-Suk
    Lee, Yeo Jin
    Kwon, Joonho
    Baek, Song-Ee
    Kim, Myeong-Jin
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (02) : 349 - 359
  • [22] Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
    Liu, Yi-Sheng
    Lin, Chia-Ying
    Chuang, Ming-Tsung
    Tsai, Yi-Shan
    Wang, Chien-Kuo
    Ou, Ming-Ching
    BMC GASTROENTEROLOGY, 2018, 18
  • [23] Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings
    Park, Hyun Jeong
    Kim, Jung Hoon
    Choi, Seo-youn
    Lee, Eun Sun
    Park, Sang Joon
    Byun, Jae Young
    Choi, Byung Ihn
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 209 (04) : W211 - W220
  • [24] Does Drug-Eluting Bead Transcatheter Arterial Chemoembolization Improve the Management of Patients with Hepatocellular Carcinoma? A Meta-Analysis
    Han, Shilong
    Zhang, Xiaoping
    Zou, Liling
    Lu, Chenhui
    Zhang, Jun
    Li, Jue
    Li, Maoquan
    PLOS ONE, 2014, 9 (08):
  • [25] Efficacy of Combined Therapy with Drug-Eluting Beads-Transcatheter Arterial Chemoembolization Followed by Conventional Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multi-Center Study
    Morishita, Asahiro
    Tani, Joji
    Nomura, Takako
    Takuma, Kei
    Nakahara, Mai
    Oura, Kyoko
    Tadokoro, Tomoko
    Fujita, Koji
    Shi, Tingting
    Yamana, Hiroki
    Matsui, Takanori
    Takata, Tadayuki
    Sanomura, Takayuki
    Nishiyama, Yoshihiro
    Himoto, Takashi
    Tomonari, Tetsu
    Moriya, Akio
    Senoo, Tomonori
    Takaguchi, Koichi
    Masaki, Tsutomu
    CANCERS, 2021, 13 (18)
  • [26] Transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma: response analysis with mRECIST
    Domaratius, Claudia
    Settmacher, Utz
    Malessa, Christina
    Teichgraeber, Ulf
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2021, 27 (01) : 85 - 93
  • [27] Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization
    Boris Gorodetski
    Julius Chapiro
    Ruediger Schernthaner
    Rafael Duran
    MingDe Lin
    Howard Lee
    David Lenis
    Elizabeth A. Stuart
    Bareng Aletta Sanny Nonyane
    Vasily Pekurovsky
    Anobel Tamrazi
    Bernhard Gebauer
    Todd Schlachter
    Timothy M. Pawlik
    Jean-Francois Geschwind
    European Radiology, 2017, 27 : 526 - 535
  • [28] Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE)
    Mariko M. Nakano
    Akira Yamamoto
    Norifumi Nishida
    Masao Hamuro
    Shinichi Hamamoto
    Atsushi Jogo
    Etsuji Sohgawa
    Ken Kageyama
    Tetsuya Minami
    Yukio Miki
    Japanese Journal of Radiology, 2019, 37 : 543 - 548
  • [29] Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
    Kuang, Donglin
    Zhang, Nan
    Zhang, Mengfan
    Li, Hao
    Han, Xinwei
    Ren, Jianzhuang
    Duan, Xuhua
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [30] Switching the Loaded Agent from Epirubicin to Cisplatin: Salvage Transcatheter Arterial Chemoembolization with Drug-eluting Microspheres for Unresectable Hepatocellular Carcinoma
    Seki, Akihiko
    Hori, Shinich
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2012, 35 (03) : 555 - 562